A trial to evaluate effectiveness of denosumab in reducing back pain related disability and improving Health Related Quality of Life (HRQoL) in women with postmenopausal osteoporosis and vertebral fractures

Trial Profile

A trial to evaluate effectiveness of denosumab in reducing back pain related disability and improving Health Related Quality of Life (HRQoL) in women with postmenopausal osteoporosis and vertebral fractures

Completed
Phase of Trial: Phase II

Latest Information Update: 18 May 2016

At a glance

  • Drugs Denosumab (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 18 May 2016 New trial record
    • 17 Apr 2016 Results presented at the 2016 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top